Inhaled corticosteroids (ICS) are recommended for asthma prevention in children. Flixotide is an ICS having a long half-life, and may use for asthma prevention in children. The aim of this study was to assess the effect of Flixotide in prevention of asthma in children. Results showed: After 3 months of prevention, asthma day's and night's symptoms symptoms were significantly improved. The requirement of SABA was decreased by duration of prevention time: 55.4 percent after 1 month, 25.3 percent after 3 months and 18 percent after 6 months. Flixotide was reduced asthma grade level, 12.1 percent of patients after 3 months and 42 percent of patients after 6 months referred to asthma grade 1. Asthma control was greatly improved with nearly 90 percent of patients having asthma control after 3 months of taking flixotide, no patients with uncontrolled asthma. In conclusion: Flixotide is an effectively asthma prevention medication for children. Flixotide helps to improve the asthma symptoms, to decrease the relief asthma medication use and to improve asthma severity degree.
- Đăng nhập để gửi ý kiến